| Dr Hsiang-fen Frances Su, MD | |
|
18321 Clark St, Tarzana, CA 91356-3501 | |
| (818) 881-0800 | |
| Not Available |
| Full Name | Dr Hsiang-fen Frances Su |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 18321 Clark St, Tarzana, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154384873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | A055195 (California) | Primary |
| Entity Name | Childrens Hospital Los Angeles Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265530653 PECOS PAC ID: 0143126920 Enrollment ID: O20031211000522 |
News Archive
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Early detection of cancer through regular screenings can greatly increase survival rates because it identifies cancer when it's most treatable, according to the National Cancer Institute.
Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1). Additional claims cover the surgical application of the NELL 1 (UCB-1) protein by several delivery agents.
Emergency medical service (EMS) providers in the United States assess an estimated 350,000 cardiac arrests each year. Only 5 to 10 percent of people who have sudden cardiac arrest survive. Better quality cardiopulmonary resuscitation (CPR) provided by prehospital EMS providers may be associated with better patient outcome. The Resuscitation Outcomes Consortium (ROC) is the largest clinical research network to study prehospital treatments for cardiac arrest in the United States and Canada.
› Verified 6 days ago
| Entity Name | Cedars-sinai Medical Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316984388 PECOS PAC ID: 0941106645 Enrollment ID: O20040202000464 |
News Archive
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Early detection of cancer through regular screenings can greatly increase survival rates because it identifies cancer when it's most treatable, according to the National Cancer Institute.
Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1). Additional claims cover the surgical application of the NELL 1 (UCB-1) protein by several delivery agents.
Emergency medical service (EMS) providers in the United States assess an estimated 350,000 cardiac arrests each year. Only 5 to 10 percent of people who have sudden cardiac arrest survive. Better quality cardiopulmonary resuscitation (CPR) provided by prehospital EMS providers may be associated with better patient outcome. The Resuscitation Outcomes Consortium (ROC) is the largest clinical research network to study prehospital treatments for cardiac arrest in the United States and Canada.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hsiang-fen Frances Su, MD 3701 Wilshire Blvd Ste 600, Los Angeles, CA 90010-2814 Ph: (323) 361-3550 | Dr Hsiang-fen Frances Su, MD 18321 Clark St, Tarzana, CA 91356-3501 Ph: (818) 881-0800 |
News Archive
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Early detection of cancer through regular screenings can greatly increase survival rates because it identifies cancer when it's most treatable, according to the National Cancer Institute.
Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1). Additional claims cover the surgical application of the NELL 1 (UCB-1) protein by several delivery agents.
Emergency medical service (EMS) providers in the United States assess an estimated 350,000 cardiac arrests each year. Only 5 to 10 percent of people who have sudden cardiac arrest survive. Better quality cardiopulmonary resuscitation (CPR) provided by prehospital EMS providers may be associated with better patient outcome. The Resuscitation Outcomes Consortium (ROC) is the largest clinical research network to study prehospital treatments for cardiac arrest in the United States and Canada.
› Verified 6 days ago
Linda Lea Perl Adatto, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 18370 Burbank Blvd, Suite 307, Tarzana, CA 91356 Phone: 818-996-6000 Fax: 818-996-4712 | |
Dr. Larry Eisenberg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 18372 Clark St, #216, Tarzana, CA 91356 Phone: 818-705-8559 Fax: 818-705-6475 | |
Jennifer Levy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 18321 Clark St, Tarzana, CA 91356 Phone: 818-881-0800 | |
Anita Giselle Wright, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4003 Clarinda Dr, Tarzana, CA 91356 Phone: 818-262-0949 | |
Breahn Faye-merie Donaldson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 18555 Ventura Blvd Ste B, Tarzana, CA 91356 Phone: 818-614-3088 | |
Malik Oscar White, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 18321 Clark St, Tarzana, CA 91356 Phone: 818-881-0800 | |
Monica P Kandavel, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 18370 Burbank Blvd, Suite 307, Tarzana, CA 91356 Phone: 818-996-6000 Fax: 818-996-4712 |